JP2004527503A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004527503A5 JP2004527503A5 JP2002569829A JP2002569829A JP2004527503A5 JP 2004527503 A5 JP2004527503 A5 JP 2004527503A5 JP 2002569829 A JP2002569829 A JP 2002569829A JP 2002569829 A JP2002569829 A JP 2002569829A JP 2004527503 A5 JP2004527503 A5 JP 2004527503A5
- Authority
- JP
- Japan
- Prior art keywords
- carbonyl
- amino
- lower alkyl
- optionally substituted
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 161
- 125000001072 heteroaryl group Chemical group 0.000 claims 46
- 125000003107 substituted aryl group Chemical group 0.000 claims 44
- 150000001875 compounds Chemical class 0.000 claims 40
- 229910052739 hydrogen Inorganic materials 0.000 claims 32
- 239000001257 hydrogen Substances 0.000 claims 32
- 125000003118 aryl group Chemical group 0.000 claims 31
- 125000000753 cycloalkyl group Chemical group 0.000 claims 29
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 29
- 150000002431 hydrogen Chemical class 0.000 claims 28
- -1 —CF 3 Chemical group 0.000 claims 25
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 23
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 21
- 229910052736 halogen Inorganic materials 0.000 claims 17
- 150000002367 halogens Chemical class 0.000 claims 17
- 125000003342 alkenyl group Chemical group 0.000 claims 16
- 229910052760 oxygen Inorganic materials 0.000 claims 15
- 229910052717 sulfur Inorganic materials 0.000 claims 14
- 125000000304 alkynyl group Chemical group 0.000 claims 11
- 208000023275 Autoimmune disease Diseases 0.000 claims 10
- 125000001475 halogen functional group Chemical group 0.000 claims 10
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 8
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 6
- 206010020751 Hypersensitivity Diseases 0.000 claims 5
- 206010061218 Inflammation Diseases 0.000 claims 5
- 230000007815 allergy Effects 0.000 claims 5
- 230000004054 inflammatory process Effects 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 229940095102 methyl benzoate Drugs 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 3
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 claims 3
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N benzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- JHQSXEMJFFLDQR-UHFFFAOYSA-N 2-[2-chloro-4-(quinoxaline-6-carbonylcarbamoylamino)phenoxy]acetic acid Chemical compound C1=C(Cl)C(OCC(=O)O)=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=N2)C2=C1 JHQSXEMJFFLDQR-UHFFFAOYSA-N 0.000 claims 2
- WKUPRCDZNFWXOH-UHFFFAOYSA-N 2-chloro-4-(quinoxaline-6-carbonylcarbamoylamino)benzoic acid Chemical compound C1=C(Cl)C(C(=O)O)=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=N2)C2=C1 WKUPRCDZNFWXOH-UHFFFAOYSA-N 0.000 claims 2
- GVJLCTNSSRYHNA-UHFFFAOYSA-N 2-hydroxy-4-(quinoxaline-6-carbonylcarbamoylamino)benzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=N2)C2=C1 GVJLCTNSSRYHNA-UHFFFAOYSA-N 0.000 claims 2
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 208000007342 Diabetic Nephropathies Diseases 0.000 claims 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 2
- 206010018364 Glomerulonephritis Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- KFJPXYHXHOOENW-UHFFFAOYSA-N N-[(3-methylphenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)C KFJPXYHXHOOENW-UHFFFAOYSA-N 0.000 claims 2
- 206010033645 Pancreatitis Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 208000033679 diabetic kidney disease Diseases 0.000 claims 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 2
- WFYHWQNNGKPZJL-UHFFFAOYSA-N n-[(3,4-dichlorophenyl)carbamoyl]-4-methyl-2,3-dihydro-1,4-benzoxazine-7-carboxamide Chemical compound C=1C=C2N(C)CCOC2=CC=1C(=O)NC(=O)NC1=CC=C(Cl)C(Cl)=C1 WFYHWQNNGKPZJL-UHFFFAOYSA-N 0.000 claims 2
- POQOCDNKLLQVEH-UHFFFAOYSA-N n-[(3-propan-2-yloxyphenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound CC(C)OC1=CC=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 POQOCDNKLLQVEH-UHFFFAOYSA-N 0.000 claims 2
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 2
- 208000037803 restenosis Diseases 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 238000002054 transplantation Methods 0.000 claims 2
- JCTRSHYQUOJCGB-UHFFFAOYSA-N 2-chloro-5-(2,3-dihydro-1,4-benzodioxine-6-carbonylcarbamoylamino)benzoic acid Chemical compound C1=C(Cl)C(C(=O)O)=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 JCTRSHYQUOJCGB-UHFFFAOYSA-N 0.000 claims 1
- CTYRPBKUPNOXMR-UHFFFAOYSA-N 2-chloro-5-(quinoxaline-6-carbonylcarbamoylamino)benzoic acid Chemical compound C1=C(Cl)C(C(=O)O)=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 CTYRPBKUPNOXMR-UHFFFAOYSA-N 0.000 claims 1
- YZIBETAXVFMICO-UHFFFAOYSA-N 2-chloro-6-(quinoxaline-6-carbonylcarbamoylamino)benzoic acid Chemical compound OC(=O)C1=C(Cl)C=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=N2)C2=C1 YZIBETAXVFMICO-UHFFFAOYSA-N 0.000 claims 1
- DZEIUSMCLZIEIB-UHFFFAOYSA-N 2-phenoxy-4-(quinoxaline-6-carbonylcarbamoylamino)benzoic acid Chemical compound OC(=O)C1=CC=C(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)C=C1OC1=CC=CC=C1 DZEIUSMCLZIEIB-UHFFFAOYSA-N 0.000 claims 1
- ATWZWWAIOSHOTC-UHFFFAOYSA-N 2-propan-2-yloxy-4-(quinoxaline-6-carbonylcarbamoylamino)benzoic acid Chemical compound C1=C(C(O)=O)C(OC(C)C)=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 ATWZWWAIOSHOTC-UHFFFAOYSA-N 0.000 claims 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 1
- RKLNGQBXZBWJOC-UHFFFAOYSA-N 3-(2,3-dihydro-1,4-benzodioxine-6-carbonylcarbamoylamino)benzoic acid Chemical compound OC(=O)C1=CC=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 RKLNGQBXZBWJOC-UHFFFAOYSA-N 0.000 claims 1
- OBELLAKXAHXDNH-UHFFFAOYSA-N 3-(quinoxaline-6-carbonylcarbamoylamino)-5-(trifluoromethyl)benzoic acid Chemical compound FC(F)(F)C1=CC(C(=O)O)=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 OBELLAKXAHXDNH-UHFFFAOYSA-N 0.000 claims 1
- DLDRGTKDMKRQHP-UHFFFAOYSA-N 3-(quinoxaline-6-carbonylcarbamoylamino)benzoic acid Chemical compound OC(=O)C1=CC=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 DLDRGTKDMKRQHP-UHFFFAOYSA-N 0.000 claims 1
- ZFUCQBFVCLXMOR-UHFFFAOYSA-N 4-(2,3-dihydro-1,4-benzodioxine-6-carbonylcarbamoylamino)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 ZFUCQBFVCLXMOR-UHFFFAOYSA-N 0.000 claims 1
- OFSZIDOVOFBWAK-UHFFFAOYSA-N 4-(quinoxaline-6-carbonylcarbamoylamino)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=N2)C2=C1 OFSZIDOVOFBWAK-UHFFFAOYSA-N 0.000 claims 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims 1
- KBKCJCHPFABMCT-UHFFFAOYSA-N 5-chloro-2-(quinoxaline-6-carbonylcarbamoylamino)benzoic acid Chemical compound OC(=O)C1=CC(Cl)=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=N2)C2=C1 KBKCJCHPFABMCT-UHFFFAOYSA-N 0.000 claims 1
- OPJQLYHXJLAUGI-UHFFFAOYSA-N C1=C(C(F)(F)F)C(C(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 Chemical compound C1=C(C(F)(F)F)C(C(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 OPJQLYHXJLAUGI-UHFFFAOYSA-N 0.000 claims 1
- DDOGEROJPSRHSE-UHFFFAOYSA-N C1=C(C(F)(F)F)C(C)=CC=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 Chemical compound C1=C(C(F)(F)F)C(C)=CC=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 DDOGEROJPSRHSE-UHFFFAOYSA-N 0.000 claims 1
- KJYDAIDIVRCAJH-UHFFFAOYSA-N C1=C(C(F)(F)F)C(F)=CC=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 KJYDAIDIVRCAJH-UHFFFAOYSA-N 0.000 claims 1
- ZZWVUDNYURUZGO-UHFFFAOYSA-N C1=C(I)C(C)=CC=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 Chemical compound C1=C(I)C(C)=CC=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 ZZWVUDNYURUZGO-UHFFFAOYSA-N 0.000 claims 1
- KJYNYZFHIFJYLH-UHFFFAOYSA-N C1=C2N(CCO)CCNC2=CC=C1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 Chemical compound C1=C2N(CCO)CCNC2=CC=C1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 KJYNYZFHIFJYLH-UHFFFAOYSA-N 0.000 claims 1
- ZHDQQXYCBXKALR-UHFFFAOYSA-N C1=C2N=C(C)C(C)=NC2=CC=C1C(=O)NC(=O)NC1=CC=CC(Br)=C1 Chemical compound C1=C2N=C(C)C(C)=NC2=CC=C1C(=O)NC(=O)NC1=CC=CC(Br)=C1 ZHDQQXYCBXKALR-UHFFFAOYSA-N 0.000 claims 1
- DCAXTIBAFMXSSP-UHFFFAOYSA-N C1=C2N=C(C)C(C)=NC2=CC=C1C(=O)NC(=O)NC1=CC=CC(C#N)=C1 Chemical compound C1=C2N=C(C)C(C)=NC2=CC=C1C(=O)NC(=O)NC1=CC=CC(C#N)=C1 DCAXTIBAFMXSSP-UHFFFAOYSA-N 0.000 claims 1
- BHDYKZNYKLVBJR-UHFFFAOYSA-N C1=C2N=C(C)C(C)=NC2=CC=C1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 Chemical compound C1=C2N=C(C)C(C)=NC2=CC=C1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 BHDYKZNYKLVBJR-UHFFFAOYSA-N 0.000 claims 1
- CJHPGOAESUKDKU-UHFFFAOYSA-N C1=CC(C(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=C(NCCN2)C2=C1 Chemical compound C1=CC(C(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=C(NCCN2)C2=C1 CJHPGOAESUKDKU-UHFFFAOYSA-N 0.000 claims 1
- LVRBXWHTSGGMGQ-UHFFFAOYSA-N C=1C=C2N(C)CCN(C)C2=CC=1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 Chemical compound C=1C=C2N(C)CCN(C)C2=CC=1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 LVRBXWHTSGGMGQ-UHFFFAOYSA-N 0.000 claims 1
- NSXIBYCAKHUNJF-UHFFFAOYSA-N C=1C=C2N(C)CCOC2=CC=1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 Chemical compound C=1C=C2N(C)CCOC2=CC=1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 NSXIBYCAKHUNJF-UHFFFAOYSA-N 0.000 claims 1
- RPCKZNIZLZRVMU-UHFFFAOYSA-N C=1C=C2N(CC)CCN(CC)C2=CC=1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 Chemical compound C=1C=C2N(CC)CCN(CC)C2=CC=1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 RPCKZNIZLZRVMU-UHFFFAOYSA-N 0.000 claims 1
- RYFUSYDRFQRZFF-UHFFFAOYSA-N C=1C=C2N(CCO)CCN(CCO)C2=CC=1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 Chemical compound C=1C=C2N(CCO)CCN(CCO)C2=CC=1C(=O)NC(=O)NC1=CC=CC(C(F)(F)F)=C1 RYFUSYDRFQRZFF-UHFFFAOYSA-N 0.000 claims 1
- LFYQTGJRYOMNQK-UHFFFAOYSA-N C=1C=C2OCCOC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1C1=CC=CC=C1 Chemical compound C=1C=C2OCCOC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1C1=CC=CC=C1 LFYQTGJRYOMNQK-UHFFFAOYSA-N 0.000 claims 1
- MCELGMQCCILXPA-UHFFFAOYSA-N C=1C=C2OCCOC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1C1=NC=CS1 Chemical compound C=1C=C2OCCOC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1C1=NC=CS1 MCELGMQCCILXPA-UHFFFAOYSA-N 0.000 claims 1
- IMFPNUOXDVGYLQ-UHFFFAOYSA-N CC(C)(C)C1=CC=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 Chemical compound CC(C)(C)C1=CC=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 IMFPNUOXDVGYLQ-UHFFFAOYSA-N 0.000 claims 1
- IENMIVXDOPOYTE-UHFFFAOYSA-N CCC1=CC=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 Chemical compound CCC1=CC=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 IENMIVXDOPOYTE-UHFFFAOYSA-N 0.000 claims 1
- CQWUFNJRPFVUTG-UHFFFAOYSA-N CCOC1=CC=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 Chemical compound CCOC1=CC=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 CQWUFNJRPFVUTG-UHFFFAOYSA-N 0.000 claims 1
- 229940126062 Compound A Drugs 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- JUNSFILCRFSAQC-UHFFFAOYSA-N FC(F)(F)C1=CC(C(F)(F)F)=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 JUNSFILCRFSAQC-UHFFFAOYSA-N 0.000 claims 1
- GDFPEDHEWNVYKY-UHFFFAOYSA-N FC(F)(F)C1=CC=CC(NC(=O)NC(=O)C=2C=C3C=CC=NC3=CC=2)=C1 Chemical compound FC(F)(F)C1=CC=CC(NC(=O)NC(=O)C=2C=C3C=CC=NC3=CC=2)=C1 GDFPEDHEWNVYKY-UHFFFAOYSA-N 0.000 claims 1
- JQSFVMSWJVHBTN-UHFFFAOYSA-N FC(F)(F)C1=CC=CC(NC(=O)NC(=O)C=2C=C3NCCNC3=CC=2)=C1 Chemical compound FC(F)(F)C1=CC=CC(NC(=O)NC(=O)C=2C=C3NCCNC3=CC=2)=C1 JQSFVMSWJVHBTN-UHFFFAOYSA-N 0.000 claims 1
- KXJBIEGYMKPDSZ-UHFFFAOYSA-N FC(F)(F)C1=CC=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 Chemical compound FC(F)(F)C1=CC=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 KXJBIEGYMKPDSZ-UHFFFAOYSA-N 0.000 claims 1
- NBKMROOYNKMVHQ-UHFFFAOYSA-N FC(F)(F)OC1=CC=CC(NC(=O)NC(=O)C=2C=C3NCCNC3=CC=2)=C1 Chemical compound FC(F)(F)OC1=CC=CC(NC(=O)NC(=O)C=2C=C3NCCNC3=CC=2)=C1 NBKMROOYNKMVHQ-UHFFFAOYSA-N 0.000 claims 1
- CDMJMVSAUGGVKK-UHFFFAOYSA-N FC(F)(F)SC1=CC=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 Chemical compound FC(F)(F)SC1=CC=CC(NC(=O)NC(=O)C=2C=C3OCCOC3=CC=2)=C1 CDMJMVSAUGGVKK-UHFFFAOYSA-N 0.000 claims 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 1
- IIQRZXPPFHLKSN-UHFFFAOYSA-N N-[(2,4-dichlorophenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=C(C=C(C=C1)Cl)Cl IIQRZXPPFHLKSN-UHFFFAOYSA-N 0.000 claims 1
- WUQUCPZRCAVKFV-UHFFFAOYSA-N N-[(2-iodophenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=C(C=CC=C1)I WUQUCPZRCAVKFV-UHFFFAOYSA-N 0.000 claims 1
- LQUQAUROGRZBCG-UHFFFAOYSA-N N-[(3,4-dichlorophenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound Clc1ccc(NC(=O)NC(=O)C2COCCO2)cc1Cl LQUQAUROGRZBCG-UHFFFAOYSA-N 0.000 claims 1
- OWEFTAFPFOVATR-UHFFFAOYSA-N N-[(3,5-dichlorophenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC(=C1)Cl)Cl OWEFTAFPFOVATR-UHFFFAOYSA-N 0.000 claims 1
- HPWNARXJWPNSKV-UHFFFAOYSA-N N-[(3-acetylphenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)C(C)=O HPWNARXJWPNSKV-UHFFFAOYSA-N 0.000 claims 1
- UBQIDRBGQSDSRT-UHFFFAOYSA-N N-[(3-bromophenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)Br UBQIDRBGQSDSRT-UHFFFAOYSA-N 0.000 claims 1
- XSKVJRKZFHEKFA-UHFFFAOYSA-N N-[(3-chloro-4-hydroxyphenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=C(C=C1)O)Cl XSKVJRKZFHEKFA-UHFFFAOYSA-N 0.000 claims 1
- SMZSKLWUWSGCOJ-UHFFFAOYSA-N N-[(3-chloro-4-hydroxyphenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound C1=C(Cl)C(O)=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=N2)C2=C1 SMZSKLWUWSGCOJ-UHFFFAOYSA-N 0.000 claims 1
- AVWPFQANRDXZHV-UHFFFAOYSA-N N-[(3-chlorophenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)Cl AVWPFQANRDXZHV-UHFFFAOYSA-N 0.000 claims 1
- FAVUDGAZOIRUER-UHFFFAOYSA-N N-[(3-cyanophenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)C#N FAVUDGAZOIRUER-UHFFFAOYSA-N 0.000 claims 1
- LWFYNHPVYRUBPC-UHFFFAOYSA-N N-[(3-iodophenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)I LWFYNHPVYRUBPC-UHFFFAOYSA-N 0.000 claims 1
- PDVFLPUXMWLPSE-UHFFFAOYSA-N N-[(3-nitrophenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound [O-][N+](=O)c1cccc(NC(=O)NC(=O)C2COCCO2)c1 PDVFLPUXMWLPSE-UHFFFAOYSA-N 0.000 claims 1
- DEVDOLVUDYZWFH-UHFFFAOYSA-N N-[(3-phenoxyphenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)OC1=CC=CC=C1 DEVDOLVUDYZWFH-UHFFFAOYSA-N 0.000 claims 1
- XSNASYYIVYVJLY-UHFFFAOYSA-N N-[(3-pyridin-2-ylphenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)C1=NC=CC=C1 XSNASYYIVYVJLY-UHFFFAOYSA-N 0.000 claims 1
- ZDDFAMLDCVZAIR-UHFFFAOYSA-N N-[(3-thiophen-2-ylphenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)C=1SC=CC=1 ZDDFAMLDCVZAIR-UHFFFAOYSA-N 0.000 claims 1
- CAHLYYTWTGBBAS-UHFFFAOYSA-N N-[(3-thiophen-3-ylphenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)C1=CSC=C1 CAHLYYTWTGBBAS-UHFFFAOYSA-N 0.000 claims 1
- DOLSVXRHAVSCFE-UHFFFAOYSA-N N-[(4-chlorophenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC=C(C=C1)Cl DOLSVXRHAVSCFE-UHFFFAOYSA-N 0.000 claims 1
- QREJGFZWWLKXIU-UHFFFAOYSA-N N-[(4-iodophenyl)carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC=C(C=C1)I QREJGFZWWLKXIU-UHFFFAOYSA-N 0.000 claims 1
- HGLPWPPZQKEGIM-UHFFFAOYSA-N N-[[3-(2H-tetrazol-5-yl)phenyl]carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)C1=NN=NN1 HGLPWPPZQKEGIM-UHFFFAOYSA-N 0.000 claims 1
- MTLOOSGPAYZVTJ-UHFFFAOYSA-N N-[[3-(furan-2-yl)phenyl]carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)C=1OC=CC=1 MTLOOSGPAYZVTJ-UHFFFAOYSA-N 0.000 claims 1
- HFAYSWLELYRFGX-UHFFFAOYSA-N N-[[3-(trifluoromethoxy)phenyl]carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC=C1)OC(F)(F)F HFAYSWLELYRFGX-UHFFFAOYSA-N 0.000 claims 1
- YQXPVKUUECMONY-UHFFFAOYSA-N N-[[3-hydroxy-5-(trifluoromethyl)phenyl]carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=CC(=C1)C(F)(F)F)O YQXPVKUUECMONY-UHFFFAOYSA-N 0.000 claims 1
- LAGHQFVCZJJHQQ-UHFFFAOYSA-N N-[[4-(2H-tetrazol-5-yl)phenyl]carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC=C(C=C1)C1=NN=NN1 LAGHQFVCZJJHQQ-UHFFFAOYSA-N 0.000 claims 1
- QSGFHTBYRQXBGP-UHFFFAOYSA-N N-[[4-(trifluoromethyl)phenyl]carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC=C(C=C1)C(F)(F)F QSGFHTBYRQXBGP-UHFFFAOYSA-N 0.000 claims 1
- YFCVHBJUZXRYQM-UHFFFAOYSA-N N-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl]-1,4-dioxane-2-carboxamide Chemical compound O1CCOCC1C(=O)NC(=O)NC1=CC(=C(C=C1)Cl)C(F)(F)F YFCVHBJUZXRYQM-UHFFFAOYSA-N 0.000 claims 1
- MWHVKNLKNIXWIC-UHFFFAOYSA-N O1CCOC2=C1C=CC(=C2)C(=O)NC(=O)NC2=CC(=CC=C2)OC(C)C Chemical compound O1CCOC2=C1C=CC(=C2)C(=O)NC(=O)NC2=CC(=CC=C2)OC(C)C MWHVKNLKNIXWIC-UHFFFAOYSA-N 0.000 claims 1
- 238000009825 accumulation Methods 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 229960004050 aminobenzoic acid Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 1
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000002955 immunomodulating agent Substances 0.000 claims 1
- 230000002584 immunomodulator Effects 0.000 claims 1
- 229940121354 immunomodulator Drugs 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000001616 monocyte Anatomy 0.000 claims 1
- CIIWRLCXEMMCAL-UHFFFAOYSA-N n-[(2,4-dichlorophenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound ClC1=CC(Cl)=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=N2)C2=C1 CIIWRLCXEMMCAL-UHFFFAOYSA-N 0.000 claims 1
- ZFSVUPSUMZSQBX-UHFFFAOYSA-N n-[(3,4-dichlorophenyl)carbamoyl]-2,3-dimethylquinoxaline-6-carboxamide Chemical compound C1=C2N=C(C)C(C)=NC2=CC=C1C(=O)NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ZFSVUPSUMZSQBX-UHFFFAOYSA-N 0.000 claims 1
- SABBIASKTUVLDU-UHFFFAOYSA-N n-[(3,4-dichlorophenyl)carbamoyl]quinoline-6-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=C2)C2=C1 SABBIASKTUVLDU-UHFFFAOYSA-N 0.000 claims 1
- UIUZGEYXVCZEHX-UHFFFAOYSA-N n-[(3,4-dichlorophenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=N2)C2=C1 UIUZGEYXVCZEHX-UHFFFAOYSA-N 0.000 claims 1
- AGMGIMKEAPUIFP-UHFFFAOYSA-N n-[(3-benzoylphenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound C=1C=C2N=CC=NC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1C(=O)C1=CC=CC=C1 AGMGIMKEAPUIFP-UHFFFAOYSA-N 0.000 claims 1
- UAWNBIDDBPBKHZ-UHFFFAOYSA-N n-[(3-bromophenyl)carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound BrC1=CC=CC(NC(=O)NC(=O)C=2C=C3NCCNC3=CC=2)=C1 UAWNBIDDBPBKHZ-UHFFFAOYSA-N 0.000 claims 1
- QCIOXVXREYECSX-UHFFFAOYSA-N n-[(3-bromophenyl)carbamoyl]-4-methyl-2,3-dihydro-1,4-benzoxazine-7-carboxamide Chemical compound C=1C=C2N(C)CCOC2=CC=1C(=O)NC(=O)NC1=CC=CC(Br)=C1 QCIOXVXREYECSX-UHFFFAOYSA-N 0.000 claims 1
- VMWRPXNXFGZLOJ-UHFFFAOYSA-N n-[(3-bromophenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound BrC1=CC=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 VMWRPXNXFGZLOJ-UHFFFAOYSA-N 0.000 claims 1
- USSURGJNWHXJIV-UHFFFAOYSA-N n-[(3-chloro-2,6-diethylphenyl)carbamoyl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide Chemical compound CCC1=CC=C(Cl)C(CC)=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 USSURGJNWHXJIV-UHFFFAOYSA-N 0.000 claims 1
- YUDXSUBMEPRTKG-UHFFFAOYSA-N n-[(3-chloro-4-hydroxyphenyl)carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound C1=C(Cl)C(O)=CC=C1NC(=O)NC(=O)C1=CC=C(NCCN2)C2=C1 YUDXSUBMEPRTKG-UHFFFAOYSA-N 0.000 claims 1
- VKDBQHLSIPFKHL-UHFFFAOYSA-N n-[(3-chloro-4-methylphenyl)carbamoyl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide Chemical compound C1=C(Cl)C(C)=CC=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 VKDBQHLSIPFKHL-UHFFFAOYSA-N 0.000 claims 1
- XZXWJRGRWYCPEI-UHFFFAOYSA-N n-[(3-chlorophenyl)-(methoxymethyl)carbamoyl]-n-(methoxymethyl)-2,3-dihydro-1,4-benzodioxine-6-carboxamide Chemical compound C=1C=C2OCCOC2=CC=1C(=O)N(COC)C(=O)N(COC)C1=CC=CC(Cl)=C1 XZXWJRGRWYCPEI-UHFFFAOYSA-N 0.000 claims 1
- VSNTXPPXIFRFKX-UHFFFAOYSA-N n-[(3-chlorophenyl)carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound ClC1=CC=CC(NC(=O)NC(=O)C=2C=C3NCCNC3=CC=2)=C1 VSNTXPPXIFRFKX-UHFFFAOYSA-N 0.000 claims 1
- QAPKCNVMZBOTNO-UHFFFAOYSA-N n-[(3-chlorophenyl)carbamoyl]-4-methyl-2,3-dihydro-1,4-benzoxazine-7-carboxamide Chemical compound C=1C=C2N(C)CCOC2=CC=1C(=O)NC(=O)NC1=CC=CC(Cl)=C1 QAPKCNVMZBOTNO-UHFFFAOYSA-N 0.000 claims 1
- MZKPODNJRQOBIT-UHFFFAOYSA-N n-[(3-chlorophenyl)carbamoyl]-n-(2-methoxyethoxymethyl)-2,3-dihydro-1,4-benzodioxine-6-carboxamide Chemical compound C=1C=C2OCCOC2=CC=1C(=O)N(COCCOC)C(=O)NC1=CC=CC(Cl)=C1 MZKPODNJRQOBIT-UHFFFAOYSA-N 0.000 claims 1
- NGGFEKHYBQZMDY-UHFFFAOYSA-N n-[(3-chlorophenyl)carbamoyl]quinoline-6-carboxamide Chemical compound ClC1=CC=CC(NC(=O)NC(=O)C=2C=C3C=CC=NC3=CC=2)=C1 NGGFEKHYBQZMDY-UHFFFAOYSA-N 0.000 claims 1
- XPZYTTWFQSVEPA-UHFFFAOYSA-N n-[(3-chlorophenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound ClC1=CC=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 XPZYTTWFQSVEPA-UHFFFAOYSA-N 0.000 claims 1
- HGPCKKQYNXNVHL-UHFFFAOYSA-N n-[(3-cyanophenyl)carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound C=1C=C2NCCNC2=CC=1C(=O)NC(=O)NC1=CC=CC(C#N)=C1 HGPCKKQYNXNVHL-UHFFFAOYSA-N 0.000 claims 1
- LHGNDIBJNJEQEQ-UHFFFAOYSA-N n-[(3-cyanophenyl)carbamoyl]-4-methyl-2,3-dihydro-1,4-benzoxazine-7-carboxamide Chemical compound C=1C=C2N(C)CCOC2=CC=1C(=O)NC(=O)NC1=CC=CC(C#N)=C1 LHGNDIBJNJEQEQ-UHFFFAOYSA-N 0.000 claims 1
- XDMKEQZRRSZDKD-UHFFFAOYSA-N n-[(3-cyanophenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound C=1C=C2N=CC=NC2=CC=1C(=O)NC(=O)NC1=CC=CC(C#N)=C1 XDMKEQZRRSZDKD-UHFFFAOYSA-N 0.000 claims 1
- ZUGGJVLYVSMTSV-UHFFFAOYSA-N n-[(3-ethynylphenyl)carbamoyl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide Chemical compound C=1C=C2OCCOC2=CC=1C(=O)NC(=O)NC1=CC=CC(C#C)=C1 ZUGGJVLYVSMTSV-UHFFFAOYSA-N 0.000 claims 1
- PGLXFIPIAABWRJ-UHFFFAOYSA-N n-[(3-iodophenyl)carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound IC1=CC=CC(NC(=O)NC(=O)C=2C=C3NCCNC3=CC=2)=C1 PGLXFIPIAABWRJ-UHFFFAOYSA-N 0.000 claims 1
- WRBBQALERFQKBE-UHFFFAOYSA-N n-[(3-phenoxyphenyl)carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound C=1C=C2NCCNC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1OC1=CC=CC=C1 WRBBQALERFQKBE-UHFFFAOYSA-N 0.000 claims 1
- BZYXGADGPVGIKQ-UHFFFAOYSA-N n-[(3-phenoxyphenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound C=1C=C2N=CC=NC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1OC1=CC=CC=C1 BZYXGADGPVGIKQ-UHFFFAOYSA-N 0.000 claims 1
- ZVXDYWQPHGTRMX-UHFFFAOYSA-N n-[(3-phenylphenyl)carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound C=1C=C2NCCNC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1C1=CC=CC=C1 ZVXDYWQPHGTRMX-UHFFFAOYSA-N 0.000 claims 1
- CEHDPNIVRONKKX-UHFFFAOYSA-N n-[(3-phenylphenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound C=1C=C2N=CC=NC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1C1=CC=CC=C1 CEHDPNIVRONKKX-UHFFFAOYSA-N 0.000 claims 1
- GFTAZVGNUNMYGJ-UHFFFAOYSA-N n-[(3-propan-2-yloxyphenyl)carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound CC(C)OC1=CC=CC(NC(=O)NC(=O)C=2C=C3NCCNC3=CC=2)=C1 GFTAZVGNUNMYGJ-UHFFFAOYSA-N 0.000 claims 1
- UCSKVPFEIKAMCE-UHFFFAOYSA-N n-[(3-propan-2-ylphenyl)carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound CC(C)C1=CC=CC(NC(=O)NC(=O)C=2C=C3NCCNC3=CC=2)=C1 UCSKVPFEIKAMCE-UHFFFAOYSA-N 0.000 claims 1
- BUPOMLLHLSKRKI-UHFFFAOYSA-N n-[(3-propan-2-ylphenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound CC(C)C1=CC=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 BUPOMLLHLSKRKI-UHFFFAOYSA-N 0.000 claims 1
- FAWWZRZKRBALGV-UHFFFAOYSA-N n-[(3-pyridin-2-ylphenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound C=1C=C2N=CC=NC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1C1=CC=CC=N1 FAWWZRZKRBALGV-UHFFFAOYSA-N 0.000 claims 1
- OUHPJKZOUVQVOQ-UHFFFAOYSA-N n-[(3-thiophen-2-ylphenyl)carbamoyl]quinoxaline-6-carboxamide Chemical compound C=1C=C2N=CC=NC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1C1=CC=CS1 OUHPJKZOUVQVOQ-UHFFFAOYSA-N 0.000 claims 1
- HUHMNUBMKANCAD-UHFFFAOYSA-N n-[(5-chloro-2-methoxyphenyl)carbamoyl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 HUHMNUBMKANCAD-UHFFFAOYSA-N 0.000 claims 1
- KPAJDZCRJADJPU-UHFFFAOYSA-N n-[(5-chloro-2-methylphenyl)carbamoyl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide Chemical compound CC1=CC=C(Cl)C=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 KPAJDZCRJADJPU-UHFFFAOYSA-N 0.000 claims 1
- YEBTXYKCOIBIPO-UHFFFAOYSA-N n-[(5-iodo-2-methylphenyl)carbamoyl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide Chemical compound CC1=CC=C(I)C=C1NC(=O)NC(=O)C1=CC=C(OCCO2)C2=C1 YEBTXYKCOIBIPO-UHFFFAOYSA-N 0.000 claims 1
- FYDSHNUQIOMSNC-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(NC(=O)NC(=O)C=2C=C3NCCNC3=CC=2)=C1 FYDSHNUQIOMSNC-UHFFFAOYSA-N 0.000 claims 1
- NGFZLQBDWGGKTK-UHFFFAOYSA-N n-[[3,5-bis(trifluoromethyl)phenyl]carbamoyl]quinoxaline-6-carboxamide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 NGFZLQBDWGGKTK-UHFFFAOYSA-N 0.000 claims 1
- UXFSYMISVNCSNO-UHFFFAOYSA-N n-[[3-(1,3-thiazol-2-yl)phenyl]carbamoyl]quinoxaline-6-carboxamide Chemical compound C=1C=C2N=CC=NC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1C1=NC=CS1 UXFSYMISVNCSNO-UHFFFAOYSA-N 0.000 claims 1
- SEZFKCBTJLIAIL-UHFFFAOYSA-N n-[[3-(furan-2-yl)phenyl]carbamoyl]quinoxaline-6-carboxamide Chemical compound C=1C=C2N=CC=NC2=CC=1C(=O)NC(=O)NC(C=1)=CC=CC=1C1=CC=CO1 SEZFKCBTJLIAIL-UHFFFAOYSA-N 0.000 claims 1
- DXQSGAJNQMHTRU-UHFFFAOYSA-N n-[[3-(trifluoromethoxy)phenyl]carbamoyl]quinoxaline-6-carboxamide Chemical compound FC(F)(F)OC1=CC=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 DXQSGAJNQMHTRU-UHFFFAOYSA-N 0.000 claims 1
- DVQDOLKEIYCZFT-UHFFFAOYSA-N n-[[3-(trifluoromethyl)phenyl]carbamoyl]quinoxaline-6-carboxamide Chemical compound FC(F)(F)C1=CC=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 DVQDOLKEIYCZFT-UHFFFAOYSA-N 0.000 claims 1
- KDXZOEPYDFHYAL-UHFFFAOYSA-N n-[[4-(trifluoromethyl)phenyl]carbamoyl]quinoxaline-6-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=N2)C2=C1 KDXZOEPYDFHYAL-UHFFFAOYSA-N 0.000 claims 1
- JICZSYIXBRGOPY-UHFFFAOYSA-N n-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC(=O)C=2C=C3NCCNC3=CC=2)=C1 JICZSYIXBRGOPY-UHFFFAOYSA-N 0.000 claims 1
- CGKCHNCCHBHMBU-UHFFFAOYSA-N n-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl]quinoxaline-6-carboxamide Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC(=O)C=2C=C3N=CC=NC3=CC=2)=C1 CGKCHNCCHBHMBU-UHFFFAOYSA-N 0.000 claims 1
- UBJCAYGEQKJEPP-UHFFFAOYSA-N n-[[4-fluoro-3-(trifluoromethyl)phenyl]carbamoyl]-1,2,3,4-tetrahydroquinoxaline-6-carboxamide Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1NC(=O)NC(=O)C1=CC=C(NCCN2)C2=C1 UBJCAYGEQKJEPP-UHFFFAOYSA-N 0.000 claims 1
- NAYUELBXBSUANY-UHFFFAOYSA-N n-[[4-fluoro-3-(trifluoromethyl)phenyl]carbamoyl]-4-methyl-2,3-dihydro-1,4-benzoxazine-7-carboxamide Chemical compound C=1C=C2N(C)CCOC2=CC=1C(=O)NC(=O)NC1=CC=C(F)C(C(F)(F)F)=C1 NAYUELBXBSUANY-UHFFFAOYSA-N 0.000 claims 1
- CYFFGEQJLLXYDJ-UHFFFAOYSA-N n-[[4-fluoro-3-(trifluoromethyl)phenyl]carbamoyl]quinoxaline-6-carboxamide Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1NC(=O)NC(=O)C1=CC=C(N=CC=N2)C2=C1 CYFFGEQJLLXYDJ-UHFFFAOYSA-N 0.000 claims 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27279201P | 2001-03-01 | 2001-03-01 | |
| PCT/US2002/006256 WO2002070509A2 (en) | 2001-03-01 | 2002-02-28 | Antagonists of mcp-1 function and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004527503A JP2004527503A (ja) | 2004-09-09 |
| JP2004527503A5 true JP2004527503A5 (cg-RX-API-DMAC7.html) | 2006-01-19 |
| JP4291576B2 JP4291576B2 (ja) | 2009-07-08 |
Family
ID=23041292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002569829A Expired - Fee Related JP4291576B2 (ja) | 2001-03-01 | 2002-02-28 | Ｍｃｐ−１機能のアンタゴニストおよびその使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6809113B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1363897B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4291576B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20040018336A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1259315C (cg-RX-API-DMAC7.html) |
| AR (1) | AR035759A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE313537T1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0207750A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2439849A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60208159T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2254653T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03007861A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI245761B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002070509A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE502928T1 (de) | 2000-11-01 | 2011-04-15 | Millennium Pharm Inc | Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| WO2006029173A2 (en) * | 2004-09-08 | 2006-03-16 | Boys Town National Research Hospital | Treatment of glomerular basement membrane disease involving matrix metalloproteinase-12 |
| MX2007012082A (es) | 2005-03-31 | 2007-11-20 | Pfizer Prod Inc | Derivados de ciclopentapiridina y tetrahidroquinolina. |
| WO2007066496A1 (en) * | 2005-12-07 | 2007-06-14 | Sumitomo Chemical Company, Limited | Benzoylurea compound and use thereof |
| US7601716B2 (en) * | 2006-05-01 | 2009-10-13 | Cephalon, Inc. | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors |
| US7919077B2 (en) * | 2006-07-24 | 2011-04-05 | Yeda Research And Development Co. Ltd. | Pharmaceutical compositions comprising CCL2 and use of same for the treatment of inflammation |
| US20080076120A1 (en) * | 2006-09-14 | 2008-03-27 | Millennium Pharmaceuticals, Inc. | Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders |
| WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| DK2091948T3 (da) | 2006-11-30 | 2012-07-23 | Probiodrug Ag | Nye inhibitorer af glutaminylcyclase |
| US20100303777A1 (en) * | 2006-12-14 | 2010-12-02 | Actogenix N.V. | Delivery of binding molecules to induce immunomodulation |
| EP2481408A3 (en) | 2007-03-01 | 2013-01-09 | Probiodrug AG | New use of glutaminyl cyclase inhibitors |
| DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
| US8356920B2 (en) * | 2007-12-12 | 2013-01-22 | Levine Jonathan E | Lighting device |
| WO2010068881A1 (en) * | 2008-12-12 | 2010-06-17 | Forest Laboratories Holdings Limited | Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligands |
| US8486940B2 (en) | 2009-09-11 | 2013-07-16 | Probiodrug Ag | Inhibitors |
| WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
| ES2481823T3 (es) | 2010-03-10 | 2014-07-31 | Probiodrug Ag | Inhibidores heterocíclicos de glutaminil ciclasa (QC, EC 2.3.2.5) |
| WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
| US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
| EP2522341A1 (en) * | 2011-05-13 | 2012-11-14 | Tragex Pharma | Pharmaceutical compositions comprising Neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers |
| TWI742513B (zh) | 2013-11-18 | 2021-10-11 | 美商弗瑪治療公司 | 作為bet溴域抑制劑之四氫喹啉組成物 |
| CN106029076B (zh) | 2013-11-18 | 2019-06-07 | 福马疗法公司 | 作为bet溴域抑制剂的苯并哌嗪组合物 |
| US20180193003A1 (en) | 2016-12-07 | 2018-07-12 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
| WO2018112264A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
| WO2018201091A1 (en) * | 2017-04-27 | 2018-11-01 | Washington University | Chemokine decoy receptors of rodent gammaherpesviruses and uses thereof |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
| EP3643711A1 (en) | 2018-10-24 | 2020-04-29 | Bayer Animal Health GmbH | New anthelmintic compounds |
| JP7482866B2 (ja) | 2018-11-19 | 2024-05-14 | ビオラ・セラピューティクス・インコーポレイテッド | 生物学的治療薬による疾患処置方法およびデバイス |
| CN121197633A (zh) | 2019-12-13 | 2025-12-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1250611A (cg-RX-API-DMAC7.html) | 1968-02-03 | 1971-10-20 | ||
| IE32700B1 (en) | 1968-02-03 | 1973-10-31 | Beecham Group Ltd | Penicillins |
| DE2131034A1 (de) * | 1971-06-23 | 1973-01-11 | Hoechst Ag | Acylharnstoffe und verfahren zu ihrer herstellung |
| DE2652004C3 (de) * | 1976-11-15 | 1979-09-13 | Basf Ag, 6700 Ludwigshafen | l-Acyl-2-arylamino-2-imidazoline, Verfahren zu ihrer Herstellung und ihre Verwendung |
| US4163784A (en) | 1978-03-09 | 1979-08-07 | Pfizer Inc. | Heterocyclylcarbonyl derivatives of urea, agents for dissolution of gallstones |
| GB8528234D0 (en) | 1985-11-15 | 1985-12-18 | Wyeth John & Brother Ltd | Heterocyclic compounds |
| JP2650055B2 (ja) | 1988-11-28 | 1997-09-03 | キヤノン株式会社 | 電子写真感光体 |
| FR2672888B1 (fr) | 1991-02-14 | 1994-02-04 | Fabre Medicament Pierre | Nouvelles urees et thiourees, leur preparation et leur application en therapeutique. |
| JP3964478B2 (ja) * | 1995-06-30 | 2007-08-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬 |
| WO1997024325A1 (en) | 1995-12-28 | 1997-07-10 | Takeda Chemical Industries, Ltd. | DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS |
| JPH09255572A (ja) | 1996-03-26 | 1997-09-30 | Takeda Chem Ind Ltd | ケモカイン受容体拮抗剤 |
| JP4176148B2 (ja) | 1996-05-20 | 2008-11-05 | 帝人ファーマ株式会社 | ジアリールアルキル環状ジアミン誘導体およびその治療薬としての使用 |
| CA2259927A1 (en) | 1996-07-12 | 1998-01-22 | Leukosite, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6140338A (en) * | 1996-07-29 | 2000-10-31 | Banyu Pharmaceutical, Co., Ltd. | Chemokine receptor antagonists |
| EP0927167A1 (en) | 1996-08-14 | 1999-07-07 | Warner-Lambert Company | 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
| WO1998027815A1 (en) | 1996-12-20 | 1998-07-02 | Merck & Co., Inc. | Substituted aminoquinolines as modulators of chemokine receptor activity |
| GB9716656D0 (en) * | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
| CA2319494A1 (en) | 1998-02-03 | 1999-08-12 | Boehringer Ingelheim Pharma Kg | 5-membered heterocyclic condensed benzoderivatives, the preparation thereof and their use as pharmaceuticals |
| AU753360B2 (en) * | 1998-07-31 | 2002-10-17 | Nippon Soda Co., Ltd. | Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
| US6316449B1 (en) * | 1999-07-08 | 2001-11-13 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists |
| EP1255741A2 (en) | 2000-02-01 | 2002-11-13 | Cor Therapeutics, Inc. | 2- 1H]-QUINOLONE AND 2- 1H]-QUINOXALONE INHIBITORS OF FACTOR Xa |
| WO2001057044A1 (en) | 2000-02-01 | 2001-08-09 | Daiichi Pharmaceutical Co., Ltd. | Pyridoxazine derivatives |
| WO2001057003A1 (en) | 2000-02-01 | 2001-08-09 | Cor Therapeutics, Inc. | 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa |
-
2002
- 2002-02-25 TW TW091103254A patent/TWI245761B/zh not_active IP Right Cessation
- 2002-02-27 US US10/087,208 patent/US6809113B2/en not_active Expired - Fee Related
- 2002-02-28 MX MXPA03007861A patent/MXPA03007861A/es active IP Right Grant
- 2002-02-28 KR KR10-2003-7011481A patent/KR20040018336A/ko not_active Abandoned
- 2002-02-28 ES ES02709746T patent/ES2254653T3/es not_active Expired - Lifetime
- 2002-02-28 EP EP02709746A patent/EP1363897B1/en not_active Expired - Lifetime
- 2002-02-28 BR BR0207750-7A patent/BR0207750A/pt not_active IP Right Cessation
- 2002-02-28 WO PCT/US2002/006256 patent/WO2002070509A2/en not_active Ceased
- 2002-02-28 CN CNB028057929A patent/CN1259315C/zh not_active Expired - Fee Related
- 2002-02-28 DE DE60208159T patent/DE60208159T2/de not_active Expired - Fee Related
- 2002-02-28 JP JP2002569829A patent/JP4291576B2/ja not_active Expired - Fee Related
- 2002-02-28 AR ARP020100728A patent/AR035759A1/es unknown
- 2002-02-28 CA CA002439849A patent/CA2439849A1/en not_active Abandoned
- 2002-02-28 AT AT02709746T patent/ATE313537T1/de not_active IP Right Cessation
-
2004
- 2004-10-19 US US10/969,440 patent/US7297696B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004527503A5 (cg-RX-API-DMAC7.html) | ||
| JP2004525951A5 (cg-RX-API-DMAC7.html) | ||
| TWI444370B (zh) | 用於發炎及免疫相關用途之噻唑及噻二唑化合物 | |
| JP4979377B2 (ja) | Ｃｒａｃイオンチャネルを阻害するための薬剤の製造における化合物の使用 | |
| JP4291576B2 (ja) | Ｍｃｐ−１機能のアンタゴニストおよびその使用方法 | |
| JP5184891B2 (ja) | 炎症及び免疫に関連する用途に用いる化合物 | |
| US6552022B1 (en) | Benzamide derivatives and their use as ApoB-100 secretion inhibitors | |
| JP2008500284A5 (cg-RX-API-DMAC7.html) | ||
| JP2010501587A5 (cg-RX-API-DMAC7.html) | ||
| CA2580852A1 (en) | Compounds for inflammation and immune-related uses | |
| KR100802332B1 (ko) | 신규한 3-치환된 요소 유도체 및 그의 의학적 용도 | |
| JP2005524668A5 (cg-RX-API-DMAC7.html) | ||
| JP2005522438A5 (cg-RX-API-DMAC7.html) | ||
| RU2009148304A (ru) | Модуляторы гидролазы амидов жирных кислот на основе гетероарилзамещенной мочевины | |
| JP2004504301A5 (cg-RX-API-DMAC7.html) | ||
| RU2006123418A (ru) | Новые антагонисты м3 мускаринового ацетилхолинового рецептора | |
| JP2004517080A5 (cg-RX-API-DMAC7.html) | ||
| JP2013517273A5 (cg-RX-API-DMAC7.html) | ||
| RU2425029C2 (ru) | Соединение сульфонамида или его соль | |
| US20060223868A1 (en) | Heterocyclic amides exhibiting and inhibitory activity at the vanilloid receptor 1(vr1) | |
| HRP20140105T1 (hr) | Novi inhibitori seh i njihova upotreba | |
| RU2012121684A (ru) | Производные оксазолина для лечения заболеваний цнс | |
| JP2005514432A5 (cg-RX-API-DMAC7.html) | ||
| CN1337961A (zh) | 用作蛋白酶抑制剂的杂芳基脒、甲基脒和胍 | |
| JP2008526988A5 (cg-RX-API-DMAC7.html) |